223 related articles for article (PubMed ID: 23728936)
1. Vitamin D bioavailability and catabolism in pediatric chronic kidney disease.
Denburg MR; Kalkwarf HJ; de Boer IH; Hewison M; Shults J; Zemel BS; Stokes D; Foerster D; Laskin B; Ramirez A; Leonard MB
Pediatr Nephrol; 2013 Sep; 28(9):1843-53. PubMed ID: 23728936
[TBL] [Abstract][Full Text] [Related]
2. Free 25-hydroxyvitamin-D concentrations are lower in children with renal transplant compared with chronic kidney disease.
Preka E; Wan M; Price KL; Long DA; Aitkenhead H; Shroff R
Pediatr Nephrol; 2020 Jun; 35(6):1069-1079. PubMed ID: 31970483
[TBL] [Abstract][Full Text] [Related]
3. Mineral metabolism and cortical volumetric bone mineral density in childhood chronic kidney disease.
Denburg MR; Tsampalieros AK; de Boer IH; Shults J; Kalkwarf HJ; Zemel BS; Foerster D; Stokes D; Leonard MB
J Clin Endocrinol Metab; 2013 May; 98(5):1930-8. PubMed ID: 23547048
[TBL] [Abstract][Full Text] [Related]
4. Racial differences in markers of mineral metabolism in advanced chronic kidney disease.
Jovanovich A; Chonchol M; Cheung AK; Kaufman JS; Greene T; Roberts WL; Smits G; Kendrick J;
Clin J Am Soc Nephrol; 2012 Apr; 7(4):640-7. PubMed ID: 22383748
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of vitamin D-binding protein and vitamin D metabolite loss in children on continuous ambulatory peritoneal dialysis.
Chen WT; Yamaoka K; Nakajima S; Tanaka Y; Yamamoto T; Satomura K; Okada S; Seino Y
Bone Miner; 1992 Jun; 17(3):389-98. PubMed ID: 1623332
[TBL] [Abstract][Full Text] [Related]
6. Bioavailable and free 25-hydroxyvitamin D and vitamin D binding protein in polycystic ovary syndrome: Relationships with obesity and insulin resistance.
Naderpoor N; Shorakae S; Abell SK; Mousa A; Joham AE; Moran LJ; Stepto NK; Spritzer PM; Teede HJ; de Courten B
J Steroid Biochem Mol Biol; 2018 Mar; 177():209-215. PubMed ID: 28734987
[TBL] [Abstract][Full Text] [Related]
7. Modified-release oral calcifediol corrects vitamin D insufficiency with minimal CYP24A1 upregulation.
Petkovich M; Melnick J; White J; Tabash S; Strugnell S; Bishop CW
J Steroid Biochem Mol Biol; 2015 Apr; 148():283-9. PubMed ID: 25446887
[TBL] [Abstract][Full Text] [Related]
8. Vitamin D-Binding Protein and the Free Hormone Hypothesis for Vitamin D in Bio-Naïve Patients with Psoriasis.
Vandikas MS; Landin-Wilhelmsen K; Gillstedt M; Osmancevic A
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163226
[TBL] [Abstract][Full Text] [Related]
9. Assessment of 24,25(OH)2D levels does not support FGF23-mediated catabolism of vitamin D metabolites.
Dai B; David V; Alshayeb HM; Showkat A; Gyamlani G; Horst RL; Wall BM; Quarles LD
Kidney Int; 2012 Nov; 82(10):1061-70. PubMed ID: 22739976
[TBL] [Abstract][Full Text] [Related]
10. Vitamin D status of children with moderate to severe chronic Kidney Disease at a Tertiary Pediatric Center in Cape Town.
Solarin AU; Nourse P; Gajjar P
Saudi J Kidney Dis Transpl; 2019; 30(4):781-794. PubMed ID: 31464234
[TBL] [Abstract][Full Text] [Related]
11. Calculated free and bioavailable vitamin D metabolite concentrations in vitamin D-deficient hip fracture patients after supplementation with cholecalciferol and ergocalciferol.
Glendenning P; Chew GT; Inderjeeth CA; Taranto M; Fraser WD
Bone; 2013 Oct; 56(2):271-5. PubMed ID: 23792937
[TBL] [Abstract][Full Text] [Related]
12. Changes of Vitamin D-Binding Protein, and Total, Bioavailable, and Free 25-Hydroxyvitamin D in Transgender People.
Chen H; Wiepjes CM; van Schoor NM; Heijboer AC; de Jongh RT; den Heijer M; Lips P
J Clin Endocrinol Metab; 2019 Jul; 104(7):2728-2734. PubMed ID: 30785996
[TBL] [Abstract][Full Text] [Related]
13. Association of Vitamin D Metabolites with Parathyroid Hormone, Fibroblast Growth Factor-23, Calcium, and Phosphorus in Dogs with Various Stages of Chronic Kidney Disease.
Parker VJ; Harjes LM; Dembek K; Young GS; Chew DJ; Toribio RE
J Vet Intern Med; 2017 May; 31(3):791-798. PubMed ID: 28186657
[TBL] [Abstract][Full Text] [Related]
14. Multiple Sclerosis Patients Show Lower Bioavailable 25(OH)D and 1,25(OH)
Vlot MC; Boekel L; Kragt J; Killestein J; van Amerongen BM; de Jonge R; den Heijer M; Heijboer AC
Nutrients; 2019 Nov; 11(11):. PubMed ID: 31731605
[TBL] [Abstract][Full Text] [Related]
15. Significance of urinary C-megalin excretion in vitamin D metabolism in pre-dialysis CKD patients.
Toi N; Inaba M; Ishimura E; Tsugawa N; Imanishi Y; Emoto M; Hirayama Y; Nakatani S; Saito A; Yamada S
Sci Rep; 2019 Feb; 9(1):2207. PubMed ID: 30778159
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of vitamin D storage in patients with chronic kidney disease: Detection of serum vitamin D metabolites using high performance liquid chromatography-tandem mass spectrometry.
Li YM; Feng Q; Jiang WQ; Wu BT; Feng JF
J Steroid Biochem Mol Biol; 2021 Jun; 210():105860. PubMed ID: 33662569
[TBL] [Abstract][Full Text] [Related]
17. FREE AND BIOAVAILABLE 25-HYDROXYVITAMIN D LEVELS IN PATIENTS WITH PRIMARY HYPERPARATHYROIDISM.
Wang X; Shapses SA; Al-Hraishawi H
Endocr Pract; 2017 Jan; 23(1):66-71. PubMed ID: 27682354
[TBL] [Abstract][Full Text] [Related]
18. FGF23 and mineral metabolism in the early post-renal transplantation period.
Wesseling-Perry K; Pereira RC; Tsai E; Ettenger R; Jüppner H; Salusky IB
Pediatr Nephrol; 2013 Nov; 28(11):2207-15. PubMed ID: 23852336
[TBL] [Abstract][Full Text] [Related]
19. Changes in vitamin D-related mineral metabolism after induction with anti-tumor necrosis factor-α therapy in Crohn's disease.
Augustine MV; Leonard MB; Thayu M; Baldassano RN; de Boer IH; Shults J; Denson LA; DeBoer MD; Herskovitz R; Denburg MR
J Clin Endocrinol Metab; 2014 Jun; 99(6):E991-8. PubMed ID: 24617709
[TBL] [Abstract][Full Text] [Related]
20. Calcitriol, calcidiol, parathyroid hormone, and fibroblast growth factor-23 interactions in chronic kidney disease.
de Brito Galvao JF; Nagode LA; Schenck PA; Chew DJ
J Vet Emerg Crit Care (San Antonio); 2013; 23(2):134-62. PubMed ID: 23566108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
